← Leaderboards
Edward D Huey
Columbia University Health Sciences
$7,793,676
Attributed
$10,555,662
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,555,662 · 6
By mechanism
R01$7,085,679 · 3
U01$2,287,120 · 1
R00$732,103 · 1
P30$450,760 · 1
Top collaborators
- Stephanie Ann Cosentino5 shared
- Gary Wayne Beecham3 shared
- Christiane Reitz3 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Scott A Small$25,024,830
- Jan Claassen$3,984,991
- Helen B Simpson$14,459,693
- Ramin V Parsey$13,126,286
- Stephanie Ann Cosentino$10,754,052
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposUnited States National Institutes Of HealthSymptomsBrainBaseResourcesBiologicalEvaluationInvestigationS DiseaseMagnetic Resonance ImagingParticipantAdverse EffectsCohortAnxietyNeuropsychiatric SymptomResponsePrefrontal CortexMemberFunctional Magnetic Resonance ImagingCostAnteriorMortalityDiagnosis
Grant awards (25)
Genetic and neuroanatomical basis of neuropsychiatric symptoms in Alzheimer's disease in populations of diverse ancestry$736,611
U01 · FY2025 · AG
Genetic and neuroanatomical basis of neuropsychiatric symptoms in Alzheimer's disease in populations of diverse ancestry$759,900
U01 · FY2024 · AG
Genetic and neuroanatomical basis of neuropsychiatric symptoms in Alzheimer's disease in populations of diverse ancestry$790,609
U01 · FY2023 · AG
Using RDoC Negative and Positive Valence Paradigms to Investigate the Mechanisms of Neuropsychiatric Symptoms (NPS) in Alzheimer's Disease and Related Dementias$439,032
R01 · FY2023 · MH · contact PI
Using RDoC Negative and Positive Valence Paradigms to Investigate the Mechanisms of Neuropsychiatric Symptoms (NPS) in Alzheimer's Disease and Related Dementias$405,000
R01 · FY2022 · MH · contact PI
Neuroanatomical associations with the factor structure underlying neuropsychiatric symptoms in Alzheimer's disease$394,829
R01 · FY2022 · AG · contact PI
Outreach, Recruitment and Engagement Core$150,639
P30 · FY2022 · AG · contact PI
Neuroanatomical associations with the factor structure underlying neuropsychiatric symptoms in Alzheimer's disease$130,176
R01 · FY2022 · AG · contact PI
Neuroanatomical associations with the factor structure underlying neuropsychiatric symptoms in Alzheimer's disease$530,267
R01 · FY2021 · AG · contact PI
Using RDoC Negative and Positive Valence Paradigms to Investigate the Mechanisms of Neuropsychiatric Symptoms (NPS) in Alzheimer's Disease and Related Dementias$405,000
R01 · FY2021 · MH · contact PI
Outreach, Recruitment and Engagement Core$146,221
P30 · FY2021 · AG · contact PI
Neuroanatomical associations with the factor structure underlying neuropsychiatric symptoms in Alzheimer's disease$510,810
R01 · FY2020 · AG · contact PI
Using RDoC Negative and Positive Valence Paradigms to Investigate the Mechanisms of Neuropsychiatric Symptoms (NPS) in Alzheimer's Disease and Related Dementias$405,000
R01 · FY2020 · MH · contact PI
Outreach, Recruitment and Engagement Core$153,900
P30 · FY2020 · AG · contact PI
Neuroanatomical associations with the factor structure underlying neuropsychiatric symptoms in Alzheimer's disease$473,900
R01 · FY2019 · AG · contact PI
Using RDoC Negative and Positive Valence Paradigms to Investigate the Mechanisms of Neuropsychiatric Symptoms (NPS) in Alzheimer's Disease and Related Dementias$420,500
R01 · FY2019 · MH · contact PI
Neuroanatomical associations with the factor structure underlying neuropsychiatric symptoms in Alzheimer's disease$496,686
R01 · FY2018 · AG · contact PI
Examination of the earliest symptoms and biomarkers of FTLD MAPT carriers$547,222
R01 · FY2016 · NS
Examination of the earliest symptoms and biomarkers of FTLD MAPT carriers$451,167
R01 · FY2015 · NS
Examination of the earliest symptoms and biomarkers of FTLD MAPT carriers$467,222
R01 · FY2014 · NS
Examination of the earliest symptoms and biomarkers of FTLD MAPT carriers$413,794
R01 · FY2013 · NS
Examination of the earliest symptoms and biomarkers of FTLD MAPT carriers$595,074
R01 · FY2012 · NS
Investigation of the dopamine system in frontotemporal dementia$234,108
R00 · FY2011 · NS · contact PI
Investigation of the dopamine system in frontotemporal dementia$248,997
R00 · FY2010 · NS · contact PI
Investigation of the dopamine system in frontotemporal dementia$248,998
R00 · FY2009 · NS · contact PI